Results 11 to 20 of about 1,077,721 (136)

Psilocybin-assisted psychotherapy for cancer patients [PDF]

open access: yesInternational Journal of Whole Person Care
Despite significant advances in symptom management for patients affected by serious illness, physicians lack effective legal treatments for individuals suffering from demoralization, death anxiety, and existential distress.
Houman Farzin
doaj   +2 more sources

The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis [PDF]

open access: yesFrontiers in Psychiatry
ObjectivePsilocybin-assisted therapy has shown promising efficacy on clinical depressive symptoms. However, diverse psychological support or psychotherapy was performed with psilocybin treatment.
Mu-Hong Chen   +17 more
doaj   +2 more sources

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence [PDF]

open access: yesTrends in Psychiatry and Psychotherapy
Eating disorders (ED) are a group of potentially severe mental disorders characterized by abnormal energy balance, cognitive dysfunction, and emotional distress.
Elena Koning, Elisa Brietzke
doaj   +2 more sources

Psilocybin-assisted psychotherapy for treatment-resistant obsessive–compulsive disorder: protocol for an open-label pilot study [PDF]

open access: yesBJPsych Open
Background Obsessive–compulsive disorder (OCD) is a debilitating mental disorder commonly treated with selective serotonin reuptake inhibitors, atypical antipsychotic augmentation and cognitive–behavioural therapy. However, up to 60% of people with OCD
Nicole Ledwos   +13 more
doaj   +2 more sources

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study

open access: yesEClinicalMedicine, 2020
Background: Psilocybin therapy has shown promise as a rapid-acting treatment for depression, anxiety, and demoralization in patients with serious medical illness (e.g., cancer) when paired with individual psychotherapy. This study assessed the safety and
Brian T Anderson   +10 more
doaj   +2 more sources

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design [PDF]

open access: yesJournal of Eating Disorders
Eating disorders (EDs) are a group of debilitating mental illnesses characterized by maladaptive eating behaviors and severe cognitive-emotional dysfunction, directly affecting 1–3% of the population.
Elena Koning   +3 more
doaj   +2 more sources

Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement

open access: yesBMJ Open
Introduction Prolonged grief disorder (PGD) represents a substantial public health issue, especially in oncology settings where it affects up to 30% of bereaved carers.
Jerome Sarris   +14 more
doaj   +2 more sources

Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report [PDF]

open access: yesJournal of Parkinson’s Disease
Background Psychedelic assisted psychotherapy (PAP) can improve treatment-resistant depression. Its usefulness in Parkinson's disease (PD) is unknown. PD patients may have problems adjusting to their chronic progressive neurological disease.
Vanessa Fleury   +3 more
doaj   +2 more sources

Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder [PDF]

open access: yesFrontiers in Pharmacology, 2018
After a hiatus of some 40 years, clinical research has resumed on the use of classic hallucinogens to treat addiction. Following completion of a small open-label feasibility study, we are currently conducting a double-blind placebo-controlled clinical ...
Michael P. Bogenschutz   +7 more
doaj   +2 more sources

Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

open access: yesPsychoactives
Psychedelic substances have experienced a resurgence of clinical interest in recent years, particularly for their promising effects in the treatment of psychiatric disorders such as depression and anxiety.
Mathilda Mercier   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy